logo
Start Application
Start Application

FAQs

FAQ

Most Popular Questions

What is stem cell therapy, and how does it work?

Stem cell therapy is a type of regenerative medicine that uses special cells and their signals to support repair in damaged tissues. Rather than acting as a rapid painkiller, stem cells release growth factors and immune-balancing signals that may help reduce inflammation, support blood flow, and improve the healing environment in the body.

Regenerative medicine focuses on helping the body repair and regenerate tissues, rather than merely controlling symptoms. Standard treatment often uses drugs or surgery to manage the disease. Regenerative approaches such as stem cell therapy and exosome therapy aim to support the body’s natural repair processes and protect remaining healthy cells.

Inceptos ut eros aptent commodo semper magna tempor pretium adipiscing. Cursus erat consequat ultrices volutpat eleifend. Ut iaculis lobortis interdum commodo eleifend at ultrices luctus lectus est. Egestas consectetur enim pharetra tempus proin ac quam accumsan efficitur quis dolor.

No. Cyrona Cell does not use embryonic stem cells or induced pluripotent stem cells in patient programmes. The clinic focuses on carefully screened umbilical cord–derived mesenchymal stem cells and related products, such as exosomes, which are used in doctor-led, minimally invasive protocols.

Stem cell and cell-based therapies in Malaysia must comply with local health regulations, ethical guidelines, and laboratory standards, such as cGMP and ISO-certified quality systems. Cyrona Cell designs its programmes to align with these requirements and uses audited laboratory processes for product preparation.

Exosome therapy uses tiny “messenger” vesicles released by cells, especially mesenchymal stem cells. These exosomes contain proteins, lipids, and genetic signals that can support repair and immune balance. Many people see exosome therapy as a cell-free extension of stem cell treatment within regenerative medicine programmes.

Safety depends on the cell source, preparation, dose, and patient health. Common short-term side effects can include mild fever, headache, or fatigue. Serious events are uncommon but must be discussed with a doctor. A responsible clinic will review medical history, explain risks clearly, and monitor patients during and after treatment.

Suitable candidates are usually medically stable people with chronic or degenerative conditions who still have meaningful function to protect or improve. The medical team considers the diagnosis, imaging results, laboratory results, current medications, and risk factors before recommending any stem cell or exosome programme.

No ethical clinic can promise a cure. Stem cell treatments are supportive and aim to improve symptoms, function, and quality of life, or to slow progression where possible. In most settings, they are used alongside standard care rather than as a replacement.

Cyrona Cell provides doctor-led programmes for conditions such as stroke, spinal cord injury, traumatic brain injury, hypoxic or anoxic brain injury, cerebral palsy, autism, Alzheimer’s disease, multiple sclerosis, osteoarthritis, joint injuries, degenerative disc disease, type 2 diabetes, kidney disease, liver disease, lung disease, inflammatory bowel disease, Crohn’s disease, ulcerative colitis, psoriasis, rheumatoid arthritis, and certain anti-aging concerns.

Stem cell therapy for stroke aims to support the injured brain by reducing inflammation, promoting blood vessel repair, and protecting stressed nerve cells. Cells are usually given by IV. The goal is to support movement, balance, speech, and cognition, especially when combined with active rehabilitation.

In spinal cord injury, stem cell treatments focus on improving the healing environment surrounding the injured spinal cord. Cells may help reduce inflammation, support blood supply, and send repair signals that can protect remaining nerve pathways. Realistic goals include improved function, reduced spasticity, or better daily independence for selected patients.

For TBI, stem cell programmes aim to reduce ongoing inflammation, support blood flow, and stabilise stressed brain tissue. This may support rehabilitation efforts targeting attention, mood, movement, and daily function. Results vary, so careful screening and follow-up are essential.

Stem cell therapy for autism and cerebral palsy is still considered exploratory. Some early human studies and real-world reports suggest potential benefits in areas such as attention, behaviour, movement, or spasticity, but responses are not guaranteed. These programmes are typically offered as supportive options alongside standard therapies.

Families should know that programmes use umbilical cord–derived MSCs, delivered in a minimally invasive way, with a strong focus on safety. The aim is to support immune balance and the overall body environment. This may help learning and daily skills in some cases, but it is not presented as a cure for autism.

Stem cell therapy for osteoarthritis and joint pain aims to calm inflammation, support cartilage signalling, and improve the joint environment. When symptoms improve, individuals can often exercise and strengthen muscles more effectively, thereby supporting joint function and daily mobility.

Joint injections deliver cells directly into the injured joint or surrounding tissue, while IV stem cell therapy sends cells through the bloodstream. Some protocols use one or both approaches depending on the injury type, imaging findings, and the overall treatment plan.

Stem cell therapies for degenerative disc disease are designed to support disc health and reduce inflammation around damaged segments. The goal is to reduce pain and improve function, sometimes helping to delay more extensive surgery in suitable cases. They do not “install a new disc,” but may support the disc environment.

Yes, Cyrona Cell offers stem cell therapy for lungs as a supportive option in conditions such as COPD and certain fibrotic lung diseases. The focus is on reducing inflammation, supporting blood vessels, and improving quality of life, alongside inhalers, rehabilitation, and oxygen therapy, as needed.

In heart failure, stem cell treatment aims to reduce inflammatory stress, support blood vessels, and protect surviving heart muscle. Cells are typically infused intravenously and used in combination with standard cardiology medications and lifestyle modifications. The aim is better stamina and daily comfort, not a guaranteed cure.

Stem cell therapy for type 2 diabetes focuses on calming inflammation, improving insulin sensitivity, and supporting metabolic balance. Some studies suggest improvements in blood sugar markers for selected patients. It is always used alongside diet, activity, and prescribed medicines.

In kidney disease, stem cell and exosome programmes aim to reduce inflammatory damage, protect remaining kidney cells, and support renal blood vessels. Realistic goals usually involve slowing decline or improving symptoms, not fully reversing advanced failure.

Stem cell therapy for liver disease aims to calm immune activity, support blood flow, and send signals that promote healthier tissue balance. It may support symptoms and liver function markers in some cases, but it does not replace liver transplantation when that is clearly needed.

Stem cell treatments for Crohn’s disease and ulcerative colitis focus on immune modulation. Mesenchymal stem cells can send anti-inflammatory signals that may help calm flares, support mucosal healing, and reduce symptoms. They are usually explored when standard IBD treatments have not given stable control.

Certain cell therapies, especially local MSC injections, have shown promise for complex perianal fistulas in Crohn’s disease. The aim is to support local healing and reduce drainage and pain. Suitability depends on fistula anatomy, prior surgeries, and overall IBD control.

In autoimmune conditions, stem cell treatments try to rebalance immune responses, reduce chronic inflammation, and protect joints or skin. Programmes for psoriasis or rheumatoid arthritis are supportive and are usually combined with dermatology or rheumatology care; they are not offered as stand-alone treatments.

Cyrona Cell uses umbilical cord–derived MSCs to support immune balance and tissue protection in MS. The goal is to reduce inflammatory stress on the nervous system and support stability. It is offered as an adjunct to neurology care, not a replacement for disease-modifying therapies.

 

Yes. Anti-aging stem cell programmes at Cyrona Cell are designed to support skin quality, recovery, energy, and overall well-being by focusing on cellular repair signals, inflammation control, and healthy lifestyle guidance. They focus on long-term support, not instant cosmetic results.

Exosome stem cell therapy at Cyrona Cell uses exosome products derived from stem cells to deliver concentrated signalling molecules. It may be used in combination with MSC therapy or as a cell-free option in certain supportive programmes for joint, skin, brain, gut, or systemic inflammation.

Most programmes are minimally invasive and delivered via intravenous infusion in a clinic setting, without major surgery. Some orthopaedic or targeted plans may use image-guided injections. Patients usually rest in a treatment chair and return to their hotel the same day.

International patients typically follow three steps: share medical reports for review, receive feedback and a proposed plan, and then attend an in-person consultation and treatment in Kuala Lumpur if the plan appears suitable. Cyrona Cell helps with timing, logistics guidance, and simple next steps.

The recommended stay depends on the programme. Many patients arrive a couple of days before treatment and remain in Malaysia for a short follow-up period. Complex cases may need a longer stay or scheduled return visits. Exact timelines are discussed after medical review.

Patients are usually asked to provide recent diagnostic reports, imaging (MRI, CT, X-rays), blood tests, specialist letters, and a list of current medications. For neurological or paediatric cases, therapy reports and developmental assessments are also helpful.

Cost depends on the condition, dose, number of sessions, inclusion of exosome therapy, and length of stay. After reviewing your medical information, Cyrona Cell can provide a personalised estimate that covers treatment costs and the likely duration of the visit.

Many patients find that stem cell therapy in Malaysia offers a combination of professional care, modern facilities, and competitive pricing compared with some Western centres. Actual value depends on the programme design, safety standards, and follow-up, not price alone.

Duration of benefit varies. Some people notice changes over weeks to months, and effects may evolve with rehab and lifestyle changes. In certain circumstances, repeat treatments may be considered. A responsible provider will discuss expected timelines and realistic progress tracking.

In most cases, yes, but this must be confirmed by the treating doctor. Certain medications, especially potent immunosuppressants or anticoagulants, may require special planning or timing. Cyrona Cell reviews your current treatment with you before scheduling any procedure.

Programmes are designed for both children (for selected conditions) and adults. Age alone is not the only factor; safety, diagnosis, and functional status are more important. The medical team evaluates each case individually.

Cyrona Cell combines doctor-led protocols, cGMP and ISO-linked laboratory standards, umbilical cord–derived MSCs, and clear communication about limits and realistic goals. The clinic focuses on multifactorial care that includes rehabilitation advice, lifestyle support, and transparent follow-up.

Treatment plans are personalised. The dose, schedule, and focus differ based on diagnosis, severity, goals, and safety factors. There is no single “one size fits all” package for every patient.

Cells are prepared in controlled laboratories with standards such as cGMP and ISO 9001–linked quality systems. Each batch is tested for identity, viability, purity, and sterility before release. Only products that meet set criteria are used in patient care.

Bone marrow stem cells are harvested from the patient’s or a donor’s bone marrow. Umbilical cord stem cells come from donated birth tissue. Umbilical cord MSCs are widely studied, have strong signalling properties, and can be prepared in advance, while bone marrow collection is more invasive.

Most Cyrona Cell programmes focus on umbilical cord–derived MSCs. In some cases, alternative options may be discussed, but the recommendation is based on safety, practicality, and the evidence base for that condition, rather than solely on patient preference.

Follow-up usually includes regular check-ins, symptom tracking, and repeat tests suggested by your local doctors or Cyrona Cell’s team. Patients may be asked to complete functional questionnaires and share updates from their specialists to monitor long-term outcomes.

This depends on your condition. Some patients with stable mobility can travel independently, while others, especially those with neurological conditions, benefit from having a family member or caregiver with them. The patient liaison can advise based on your case.

All information shared is handled in accordance with privacy and data protection practices that comply with Malaysian requirements. Medical records are used only to review suitability, plan treatment, and manage follow-up, and are not shared with third parties without consent, except where required by law.

Yes, and this is often encouraged. Many programmes are designed to work alongside physiotherapy, occupational therapy, speech therapy, or other rehabilitation services. A combined approach can support better functional outcomes.

The best way is a structured medical review. Share your diagnosis, reports, and goals with the Cyrona Cell team. They can explain if a programme is likely to be suitable, what it can realistically offer, and how it fits with your existing care.

You should ask about: the exact cell type and source, lab standards, dosing and schedule, expected benefits, known risks, alternative options, total costs, follow-up plans, and what will happen if you do not respond as hoped. Clear answers are an important part of informed consent.

You can begin by completing the online application form and uploading basic medical reports. A patient liaison will review your information with the medical team and then contact you with feedback, possible programme options, and next steps if stem cell therapy in Malaysia looks appropriate for your situation.

Download our booklet

Download a PDF